Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma.

Though, the difference did not reach statistical significance in the GSE145996 and GSE35640 cohorts, we still observed a higher immune therapy response rate in GPCR low /TME high group compared to others (Fig. 8 D–E).

also in 111,027 other papers